Idiopathic Polymorphic Ventricular Tachycardia

Authors

  • Hussein Rabah Department of Medicine, Staten Island University Hospital, New York, USA. https://orcid.org/0000-0001-9820-3209
  • Georges Khattar Department of Medicine, Staten Island University Hospital, New York, USA.
  • Ali Rabah Beirut Cardiac Institute, Division of Electrophysiology, Beirut, Lebanon.

DOI:

https://doi.org/10.9734/bpi/nramms/v2/6049B

Keywords:

Dopamine, idiopathic ventricular fibrillation, polymorphic ventricular tachycardia

Abstract

Idiopathic polymorphic ventricular tachycardia (IPVT) is a life-threatening arrhythmia triggered by short-coupled premature ventricular contractions (PVC) and is a rare cause of sudden death in patients with structurally normal hearts. It is a diagnosis of exclusion where ischemia and other structural heart diseases, in addition to channelopathies should be ruled out. Although an implantable cardioverter-defibrillator (ICD) is indicated to prevent sudden death, many patients require adjuvant antiarrhythmic drugs or ablation of PVCs initiating IPVT/VF.

Published

2023-09-06

How to Cite

Hussein Rabah, Georges Khattar, & Ali Rabah. (2023). Idiopathic Polymorphic Ventricular Tachycardia. Novel Research Aspects in Medicine and Medical Science Vol. 2, 8–13. https://doi.org/10.9734/bpi/nramms/v2/6049B

Issue

Novel Research Aspects in Medicine and Medical Science Vol. 2

Section

Chapters